Radient Pharmaceuticals Corporation fka RXPC

[GetSeriousOK]

Provista wants nothing to do with RXPC.

Eventually, you will understand. Not this year, apparently. Oh well, no harm done. One thing is for certain: you won't lose any more money on RXPC stock.

Someday, Provista will probably go public. I guess the Provista Merger rumor will finally die that day... but not until. And even then, the RXPC Shareholders won't give up the Creeping Backdoor Creative Triangular Merger rumor -- they'll just find a new "buyer" to plug in. UNI? Astellas? Johnson & Johnson? Whatever. Dreaming is free.